- All
- Company news
- CPHI 2025
- Events & Trade Fairs
- GCSG 2025
- New medicines
Comprehensive Guide to Choosing a Reliable and Vital Drug Supplier in Europe
Complete Guide to Choosing Vital Drug Suppliers in Europe
International medicine Logistics: Challenges and Practical Solutions from Lenus Health’s Perspective
Challenges and Practical Solutions
Lenus Health Exclusive Report from MEDICA 2025 Somewhere Between Innovation, Crowds, and Life-Saving Coffee
Exploring Opportunities and Market Trends
Our Experience at CPhI Frankfurt 2025: Exploring Opportunities and Market Trends
Exploring Opportunities and Market Trends
Participation in GCSG 2025 European Knowledge Forum – Exchange of Knowledge and Emerging Trends in Pharmaceutical Supply
At Lenus Health, we are constantly moving forward to enhance…
Lurbinectedin and Atezolizumab in the Treatment of Advanced Small Cell Lung Cancer (ES-SCLC)
Lurbinectedin and Atezolizumab in Advanced ES-SCLC Treatment
FDA Approval of Imlunestrant for ER-Positive, HER2-Negative, ESR1-Mutated Breast Cancer
FDA Approval of Imlunestrant for ESR1-Mutated Breast Cancer